Dexamethasone a Potential Treatment for Cancer-Related Fatigue (JOCO)
Dexamethasone (Photo credit: Wikipedia) |
Highlight:
"Prior research demonstrating the benefit of steroids in advanced cancer patients is limited, and there are no validated studies using fatigue as a primary outcome,” he said. The study he led (senior author was Eduardo Bruera, MD) used validated tools in a controlled setting that met National Cancer Institute and National Comprehensive Cancer Network criteria. Moreover, the study demonstrated that dexamethasone at 4 mg twice daily was effective in treating cancer-related fatigue for a period of two weeks."
Link to full article here.
0 comments:
Post a Comment